Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does APREMILAST Cause Incorrect product administration duration? 59 Reports in FDA Database

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

According to the FDA Adverse Event Reporting System (FAERS), 59 reports of Incorrect product administration duration have been filed in association with APREMILAST (Otezla). This represents 0.0% of all adverse event reports for APREMILAST.

59
Reports of Incorrect product administration duration with APREMILAST
0.0%
of all APREMILAST reports
55
Deaths
54
Hospitalizations

How Dangerous Is Incorrect product administration duration From APREMILAST?

Of the 59 reports, 55 (93.2%) resulted in death, 54 (91.5%) required hospitalization, and 54 (91.5%) were considered life-threatening.

Is Incorrect product administration duration Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for APREMILAST. However, 59 reports have been filed with the FAERS database.

What Other Side Effects Does APREMILAST Cause?

Diarrhoea (23,752) Nausea (21,352) Psoriasis (19,255) Headache (17,024) Drug ineffective (14,121) Abdominal discomfort (7,653) Psoriatic arthropathy (7,035) Vomiting (5,959) Rash (5,883) Pain (5,676)

What Other Drugs Cause Incorrect product administration duration?

ETONOGESTREL (3,974) POLYETHYLENE GLYCOL 3350 (2,129) NIRMATRELVIR\RITONAVIR (744) DOCOSANOL (634) LANSOPRAZOLE (564) LOPERAMIDE (543) NAPROXEN (499) INSULIN LISPRO (479) DICLOFENAC (362) OMEPRAZOLE (302)

Which APREMILAST Alternatives Have Lower Incorrect product administration duration Risk?

APREMILAST vs APREPITANT APREMILAST vs APROTININ APREMILAST vs ARANESP APREMILAST vs ARAVA APREMILAST vs AREDIA

Related Pages

APREMILAST Full Profile All Incorrect product administration duration Reports All Drugs Causing Incorrect product administration duration APREMILAST Demographics